Influenza vaccination of the elderly is associated with direct medical care cost savings

International Congress Series

Volumn 1263, Issue C, 2004, Pages 658-660

  Nichol, K L ^a,b,c   Nordin, J ^c   Mullooly, J ^d   Lask, R ^e  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^d KAISER PERMANENTE   (United States)

^e Oxford Health Plan   (United States)

Author keywords

Cost effectiveness; Geriatrics; Influenza; Vaccination

Indexed keywords

EID: 77956291287     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.02.037     Document Type: Article

References (7)

1. Centers for Disease Control and Prevention, Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 52:RR-8 (2003), 1–34.
2. Nichol, K.L., The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21 (2003), 1769–1775.
3. Nichol, K.L., et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J. Med. 348 (2003), 1322–1332.
4. Clemmer, B, Haddix, A.C., Cost-benefit analysis. Haddix, A.C., Teutsch, S.M., Shaffer, P.A., Dunet, D.O., (eds.) Prevention Effectiveness. A Guide to Decision Analysis and Economic Evaluation, 1996, Oxford Univ. Press, New York, 85–102.
5. Haddix, A.C., Shaffer, P.A., Cost-effectiveness analysis. Haddix, A.C., Teutsch, S.M., Shaffer, P.A., Dunet, D.O., (eds.) Prevention Effectiveness. A Guide to Decision Analysis and Economic Evaluation, 1996, Oxford Univ. Press, New York, 103–129.
6. Nordin, J, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J. Infect. Dis. 184 (2001), 665–670.
7. Hak, E, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed care organizations. Clin. Infect. Dis. 35 (2002), 370–377.